Illumina Signs Master Supply Agreement with LabCorp

Illumina

today announced it has entered into a multi-year supply agreement with Laboratory Corporation of America® Holdings (LabCorp®)

. The agreement gives LabCorp expanded rights to use Illumina next-generation sequencing (NGS) and microarray equipment and supplies to develop, validate and introduce laboratory-developed tests to clinicians in the United States and Canada.